Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatChemical/toxinWistarMalen = 35 ratsOral250 and 500 mg/kg body weightPretreatment before induction of myocardial necrosis, with isoprenaline given o…
Model: Isoprenaline-induced myocardial infarction, isoprenaline 85 mg/kg subcutaneously on days 19 and 20 of the pretreatment period
Cardiac enzyme levels altered by isoprenaline were significantly restored by the extract, most clearly at 500 mg/kg (ALT, AST, CK-MB and LDH all p<0.0001), with supporting physical and histopathological findings comparable to the standard drugs.
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.